Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH
Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH
USE OUR INTELLIGENCE

New Insights on Antibody Responses to Omicron Variants
VIRUSES & VACCINES
October 30, 2022

New Insights on Antibody Responses to Omicron Variants

Understanding antibody responses will be key to offset coronavirus variants’ evasion of earlier immunity Knowing how…

USE OUR INTELLIGENCE October 30, 2022
After Rehab for Opioids, Nearly Half of Medicaid Beneficiaries Do Not Receive Follow-Up Care
DISEASES
October 27, 2022

After Rehab for Opioids, Nearly Half of Medicaid Beneficiaries Do Not Receive Follow-Up Care

Despite strong evidence for the importance of outpatient care after inpatient residential treatment for opioid…

USE OUR INTELLIGENCE October 27, 2022
OpenBiome Announces Global Expansion
RESEARCH
October 27, 2022

OpenBiome Announces Global Expansion

OpenBiome announces the expansion of its mission to catalyze microbiome research on a global scale. The…

USE OUR INTELLIGENCE October 27, 2022
Auto Draft
PUBLIC HEALTH
October 27, 2022

Annenberg Debuts Science and Public Health Knowledge Monitor

The Annenberg Public Policy Center of the University of Pennsylvania is launching a science and…

USE OUR INTELLIGENCE October 27, 2022
Annual Report to the Nation: Cancer Deaths Continue Downward Trend; Modest Improvements in Survival for Pancreatic Cancer
DISEASES
October 27, 2022

Annual Report to the Nation: Cancer Deaths Continue Downward Trend; Modest Improvements in Survival for Pancreatic Cancer

Overall cancer death rates continued to decline among men, women, children, and adolescents and young…

USE OUR INTELLIGENCE October 27, 2022
Why Immunotherapy Works Well for Some Cancer Patients, but Not Others
DISEASES
October 27, 2022

Why Immunotherapy Works Well for Some Cancer Patients, but Not Others

Immunotherapy, a biotherapy that boosts the ability of the immune system to recognize and attack…

USE OUR INTELLIGENCE October 27, 2022
Can Smartphones Predict Mortality Risk?
TECHNOLOGY
October 21, 2022

Can Smartphones Predict Mortality Risk?

Passive smartphone monitoring of people’s walking activity can be used to construct population-level models of…

USE OUR INTELLIGENCE October 21, 2022
A ‘Door’ into the Mitochondrial Membrane
NEUROLOGY & MENTAL HEALTH
October 21, 2022

A ‘Door’ into the Mitochondrial Membrane

Mitochondria — the organelles responsible for energy production in human cells — were once free-living organisms…

USE OUR INTELLIGENCE October 21, 2022
Fatty Liver Linked to Survival in E. Coli Infection
DISEASES
October 21, 2022

Fatty Liver Linked to Survival in E. Coli Infection

Scientists at UC San Francisco (UCSF) have developed a new way of looking at sex-biased…

USE OUR INTELLIGENCE October 21, 2022
Scripps Research Scientists Map Key Protein Structure of Hepatitis C Virus
VIRUSES & VACCINES
October 21, 2022

Scripps Research Scientists Map Key Protein Structure of Hepatitis C Virus

A team led by scientists at Scripps Research and the University of Amsterdam has achieved…

USE OUR INTELLIGENCE October 21, 2022
Older Posts Newer Posts
Latest Posts
  • Check for Copycat Bias in Medical AI
    TECHNOLOGY
    Check for Copycat Bias in Medical AI
    USE OUR INTELLIGENCE September 2, 2026
  • Brain Cancer: Immunotherapy First, Surgery Afterwards
    NEUROLOGY & MENTAL HEALTH, PHARMA & CLINICAL TRIALS
    Brain Cancer: Immunotherapy First, Surgery Afterwards
    USE OUR INTELLIGENCE September 2, 2026
  • Your Smartwatch Is Lying to You About How Many Calories You Burned, FIU Study Finds
    TECHNOLOGY
    Your Smartwatch Is Lying to You About How Many Calories You Burned, FIU Study Finds
    USE OUR INTELLIGENCE September 2, 2026
  • FDA Approves Breakthrough Pancreatic Cancer Drug – an Oncologist Explains How Daraxonrasib Nearly Doubles Survival
    PHARMA & CLINICAL TRIALS
    FDA Approves Breakthrough Pancreatic Cancer Drug – an Oncologist Explains How Daraxonrasib Nearly Doubles Survival
    USE OUR INTELLIGENCE September 2, 2026
  • Not All ‘Magic’ Mushrooms Are the Same
    PUBLIC HEALTH
    Not All ‘Magic’ Mushrooms Are the Same
    USE OUR INTELLIGENCE September 2, 2026
Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH

©2026. Global Health News Wire. Use Our Intel. All Rights Reserved. Washington, D.C.

Global Health News Wire
  • HOME
  • GHNW Notes
  • PERMISSIONS AND POLICIES
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH

©2026. Global Health News Wire. Use Our Intel. All Rights Reserved. Washington, D.C.

I would like to receive critical industry news to my inbox.

Our site uses cookies. Learn more about our use of cookies: Cookie Policy

ACCEPT